Cardiovascular Panel
At home or in a lab4 advanced biomarkers (on top of the base 50+) · Lifeforce
Advanced cardiac add-on with TMAO, NMR lipoprotein profiling, ferritin, and GlycA layered on the member diagnostic
Add-on brain panel with ApoE genetic risk plus pTau-217, beta-amyloid 42/40, and GFAP markers for early Alzheimer's signal
The Brain Protection Panel is an add-on blood panel for Lifeforce members and one-time-diagnostic purchasers. It layers four research-grade brain biomarkers; ApoE (a one-time genetic test for late-onset Alzheimer's risk), pTau-217 (tau tangles), Beta-Amyloid 42/40 Ratio (amyloid plaques), and GFAP (brain injury and neuroinflammation); on top of the standard 50+ biomarker panel. Several of these markers only recently moved from research labs into consumer testing. Results are read against optimization-range targets via the Lifescore, then reviewed by a board-certified clinician during a telehealth consult; not shipped as a standalone report.
Results are interpreted by a board-certified Lifeforce clinician during the scheduled telehealth consult alongside the base biomarker panel; not delivered as a standalone report.
The panel separates genetic risk from active disease signal. ApoE runs once and tells you your inherited risk for late-onset Alzheimer's. The three plasma markers; pTau-217, Beta-Amyloid 42/40 Ratio, and GFAP; are serial: they track whether tau tangles, amyloid plaques, or glial injury are actually measurable now, and how those numbers move across quarterly retests. A Lifeforce clinician reads all four in the context of the base panel, then builds a brain-health plan around what the biology is doing, not just what your genotype predicts.
This panel is a deeper layer on top of; not a replacement for; the standard biomarkers already covered by the Lifeforce base diagnostic (inflammation, metabolic, organ health). It is not sold as a standalone DTC kit. ApoE genotyping is run once; subsequent retests drop ApoE and re-run only the three plasma markers (pTau-217, Beta-Amyloid 42/40, GFAP) via the follow-up SKU.
Results are read against optimization-range targets rather than abnormal/normal cutoffs and rolled into the Lifeforce Lifescore (1–100 index) alongside the base panel. Specific clinical cutoffs for plasma pTau-217 and Beta-Amyloid 42/40 aren't published on the product page.
A licensed phlebotomist visits your home to collect the base 50+ biomarker draw plus the four brain markers. ApoE genotyping runs once; the three plasma markers run on each retest.
Results flow into the Lifeforce dashboard and into the proprietary Lifescore. A board-certified Lifeforce clinician analyzes the brain panel in context with the full biomarker picture.
You meet virtually with your clinician to review the brain results alongside the rest of the panel. Output is a personalized plan; supplements, prescription medications where indicated, nutrition, and lifestyle strategies aimed at measurable brain-health targets.
Retest every three months on the standard Lifeforce cadence; the follow-up SKU re-runs pTau-217, Beta-Amyloid 42/40, and GFAP without repeating the one-time ApoE genotype. A Health Coach supports execution between consults.
4 advanced biomarkers (on top of the base 50+) · Lifeforce
Advanced cardiac add-on with TMAO, NMR lipoprotein profiling, ferritin, and GlycA layered on the member diagnostic
$ · From $200 · 3 heavy-metal biomarkers · Lifeforce
Heavy-metals panel measuring arsenic, mercury, and lead for exposure concerns or unexplained symptoms
Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.